Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis

Ximei Zhang, Feng Huang, Yanming Chen, Xiaoxian Qian, Song Guo Zheng

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Atherosclerosis is a chronic inflammatory disease of the arterial intima, occurring usually in the aged populations who are suffering from hypertension, dyslipidemia and diabetes for a long time. Research on atherosclerosis has shown that macrophage foam cell formation, inflammation, dyslipidemia and immune cells infiltration are all involved in regulating the onset and progression of atherosclerosis. Mesenchymal stem cells (MSCs) originated from different kinds of tissue are a group of cells possessing well-established self-renewal and multipotent differentiation properties as well as immunomodulatory and anti-inflammatory roles. Recent studies have displayed their dyslipidemia regulation functions. Transplantation of MSCs to atherosclerotic patients might be a new multifactorial therapeutic strategy to improve atherosclerosis. This review updates the advancement on MSCs and atherosclerosis.

Original languageEnglish (US)
Article numberAJTR0037131
Pages (from-to)4017-4024
Number of pages8
JournalAmerican Journal of Translational Research
Issue number10
StatePublished - Oct 30 2016

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Clinical Biochemistry
  • Cancer Research


Dive into the research topics of 'Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis'. Together they form a unique fingerprint.

Cite this